152 related articles for article (PubMed ID: 16112176)
1. Invasive potency related to RCAS1 expression in uterine cervical cancer.
Sonoda K; Miyamoto S; Hirakawa T; Yagi H; Yotsumoto F; Nakashima M; Watanabe T; Nakano H
Gynecol Oncol; 2005 Oct; 99(1):189-98. PubMed ID: 16112176
[TBL] [Abstract][Full Text] [Related]
2. [Expressions of receptor-binding cancer antigen expressed on SiSo cells, vascular endothelial growth factor, and matrix metalloproteinase-9 in cervical carcinoma and correlation thereof with the invasion and metastasis of the cancerous tissues].
Liu R; Pu DM; Cheng YX; Yin L
Zhonghua Yi Xue Za Zhi; 2007 May; 87(19):1326-9. PubMed ID: 17727777
[TBL] [Abstract][Full Text] [Related]
3. Association between RCAS1 expression and microenvironmental immune cell death in uterine cervical cancer.
Sonoda K; Miyamoto S; Hirakawa T; Yagi H; Yotsumoto F; Nakashima M; Watanabe T; Nakano H
Gynecol Oncol; 2005 Jun; 97(3):772-9. PubMed ID: 15943986
[TBL] [Abstract][Full Text] [Related]
4. The clinical significance of tumor-associated antigen RCAS1 expression in the normal, hyperplastic, and malignant uterine endometrium.
Sonoda K; Kaku T; Hirakawa T; Kobayashi H; Amada S; Sakai K; Nakashima M; Watanabe T; Nakano H
Gynecol Oncol; 2000 Dec; 79(3):424-9. PubMed ID: 11104614
[TBL] [Abstract][Full Text] [Related]
5. [Relationship between expression of matrix metalloproteinase (MMP-9) and tumor angiogenesis, cancer cell proliferation, invasion, and metastasis in invasive carcinoma of cervix].
Jiang ZQ; Zhu FC; Qu JY; Zheng X; You CL
Ai Zheng; 2003 Feb; 22(2):178-84. PubMed ID: 12600296
[TBL] [Abstract][Full Text] [Related]
6. Expression of RCAS1 in esophageal squamous cell carcinoma is associated with a poor prognosis.
Kato H; Nakajima M; Masuda N; Faried A; Sohda M; Fukai Y; Miyazaki T; Fukuchi M; Tsukada K; Kuwano H
J Surg Oncol; 2005 May; 90(2):89-94. PubMed ID: 15844180
[TBL] [Abstract][Full Text] [Related]
7. The level of RCAS1 expression is inversely correlated with the number of vimentin-positive stromal cells in epithelial ovarian cancer.
Sonoda K; Miyamoto S; Kobayashi H; Ogawa S; Okugawa K; Taniguchi S; Wake N
Int J Gynecol Cancer; 2009 Jul; 19(5):838-43. PubMed ID: 19574770
[TBL] [Abstract][Full Text] [Related]
8. Biologic significance of receptor-binding cancer antigen expressed on SiSo cells (RCAS1) as a pivotal regulator of tumor growth through angiogenesis in human uterine cancer.
Sonoda K; Miyamoto S; Yamazaki A; Kobayashi H; Nakashima M; Mekada E; Wake N
Cancer; 2007 Nov; 110(9):1979-90. PubMed ID: 17849467
[TBL] [Abstract][Full Text] [Related]
9. EMMPRIN expression as a prognostic factor in radiotherapy of cervical cancer.
Ju XZ; Yang JM; Zhou XY; Li ZT; Wu XH
Clin Cancer Res; 2008 Jan; 14(2):494-501. PubMed ID: 18223224
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of RCAS1 as a biomarker of uterine cancer.
Sonoda K; Miyamoto S; Hirakawa T; Yagi H; Yotsumoto F; Nakashima M; Watanabe T; Nakano H
Gynecol Oncol; 2006 Dec; 103(3):924-31. PubMed ID: 16842844
[TBL] [Abstract][Full Text] [Related]
11. The immunohistochemical analysis of antigens such as RCAS1 and B7H4 in the cervical cancer nest and within the fibroblasts and macrophages infiltrating the cancer microenvironment.
Galazka K; Opławski M; Windorbska W; Skret-Magierlo J; Koper K; Basta P; Mach P; Dutch-Wicherek M; Mazur A; Wicherek L
Am J Reprod Immunol; 2012 Jul; 68(1):85-93. PubMed ID: 22530960
[TBL] [Abstract][Full Text] [Related]
12. [The expression of matrix metalloproteinase-2 and -9 in cervical cancer and a study of their relationship].
Ouyang YW; Peng ZL; Yao XY; Liu SL; He YD
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 May; 35(3):330-3. PubMed ID: 15181827
[TBL] [Abstract][Full Text] [Related]
13. Clusterin expression predicts survival of invasive cervical cancer patients treated with radical hysterectomy and systematic lymphadenectomy.
Watari H; Ohta Y; Hassan MK; Xiong Y; Tanaka S; Sakuragi N
Gynecol Oncol; 2008 Mar; 108(3):527-32. PubMed ID: 18177691
[TBL] [Abstract][Full Text] [Related]
14. Relationship between decreased expression of squamous cell carcinoma antigen 2 and E-cadherin in primary cervical cancer lesions and lymph node metastasis.
Murakami A; Nakagawa T; Fukushima C; Torii M; Sueoka K; Nawata S; Takeda O; Ishikawa H; Sugino N
Oncol Rep; 2008 Jan; 19(1):99-104. PubMed ID: 18097581
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of matrix metalloproteinase-2 in cancer of uterine cervix: a semiquantitative study of immunoreactivities using tissue array.
Wang PH; Ko JL; Tsai HT; Yang SF; Han CP; Lin LY; Chen GD
Gynecol Oncol; 2008 Mar; 108(3):533-42. PubMed ID: 18177928
[TBL] [Abstract][Full Text] [Related]
16. Protein and gene expression of tumor-associated antigen RCAS1 in esophageal squamous cell carcinoma.
Ikeguchi M; Ohoro S; Maeda Y; Yamaguchi K; Fukuda K; Shirai H; Kondo A; Tsujitani S; Kaibara N
Oncol Rep; 2003; 10(6):1891-4. PubMed ID: 14534714
[TBL] [Abstract][Full Text] [Related]
17. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study.
Bacman D; Merkel S; Croner R; Papadopoulos T; Brueckl W; Dimmler A
BMC Cancer; 2007 Aug; 7():156. PubMed ID: 17692120
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of cystic fibrosis transmembrane conductance regulator (CFTR) is associated with human cervical cancer malignancy, progression and prognosis.
Peng X; Wu Z; Yu L; Li J; Xu W; Chan HC; Zhang Y; Hu L
Gynecol Oncol; 2012 May; 125(2):470-6. PubMed ID: 22366595
[TBL] [Abstract][Full Text] [Related]
19. Cyclooxygenase-2 expression in squamous cell carcinoma of the uterine cervix is associated with lymph node metastasis.
Khunamornpong S; Settakorn J; Sukpan K; Srisomboon J; Ruangvejvorachai P; Thorner PS; Siriaunkgul S
Gynecol Oncol; 2009 Jan; 112(1):241-7. PubMed ID: 18977022
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of the expression of tumor-associated antigen, RCAS1, and its soluble protein in pleural fluid in malignant mesothelioma.
Hiraki A; Aoe K; Murakami T; Nakamura Y; Yamazaki K; Sueoka N; Taguchi K; Kamei T; Maeda T; Takeyama H; Kishimoto T; Nishimura M; Sugi K
Oncol Rep; 2005 Aug; 14(2):357-62. PubMed ID: 16012715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]